Allison Hulme

Allison Hulme

Chief Executive Officer at
Aeovian Pharmaceuticals, Inc.
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Allison J.
Hulme
is a President, Chief Executive Officer & Director at Aeovian Pharmaceuticals, Inc. She is on the Board of Directors at Aeovian Pharmaceuticals, Inc. and InteKrin Therapeutics, Inc. Dr. Hulme was previously employed as an Independent Director by Ventyx Biosciences, Inc., an Executive Vice President & Head-Global Development by Elan Corp.
Plc, an Executive Vice President & Head-Global Development by Elan Pharmaceuticals, Inc., and a Principal by Glaxo Wellcome Plc.
She also served on the board at Sophiris Bio, Inc. She received her undergraduate degree from the University of Luton and a doctorate degree from Cranfield University.

Allison Hulme active positions

CompaniesPositionStart
Director/Board Member 01/01/2013
Chief Executive Officer 01/01/2020

Former positions of Allison Hulme

CompaniesPositionEnd
VENTYX BIOSCIENCES, INC. Director/Board Member 04/03/2026
Corporate Officer/Principal 01/10/2009
Corporate Officer/Principal 01/01/2005
Corporate Officer/Principal -
SOPHIRIS BIO Chief Tech/Sci/R&D Officer 31/12/2019
See the detail of Allison Hulme's experience

Training of Allison Hulme

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology